Coverage-gated living condition brief

HIV Infections peptide evidence brief

A cited HIV Infections peptide evidence brief across 30 exact-label ClinicalTrials.gov records, 5 connected profiles, and 10 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

30 selected records.

Connected peptides

5 profiles.

Registry update years

2005–2026 in selected records.

Direct collection answer · published August 17, 2026

What peptide evidence does PeptideScanner carry for HIV Infections?

PeptideScanner’s selected collection contains 30 retained ClinicalTrials.gov records carrying the exact condition label “HIV Infections,” connected to 5 peptide profiles across 10 registry-update years.

That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats HIV Infections, and it is not a safety or efficacy assessment.

Indication intelligence

Selected evidence landscape

Trial phases5

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 116 selected PubMed records and 3 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern HIV Infections unless their own cited source says so.

Related profile context

Literature connected through these peptide profiles

All literature facets →

This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern HIV Infections.

Enfuvirtide · source record 2026-10-11

Enfuvirtide.

PubMed lists PMID 14664654 in Drugs as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Thymopentin · source record 2026-10-20

Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.

PubMed lists PMID 2863860 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Metreleptin · source record 2026-11-09

Metreleptin treatment of non-HIV lipodystrophy syndromes.

PubMed lists PMID 34571177 in Presse medicale (Paris, France : 1983) as Journal Article, Review, with publication-date metadata of 2021-09-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Tesamorelin · source record 2021-10-21

Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Thymosin alpha-1 · source record 2026-09-29

Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.

PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Enfuvirtide · source record 2026-05-18

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.

PubMed lists PMID 19461505 in AIDS (London, England) as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-07-17 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Open attributed literature record →

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00001118

PeptideScanner retained ClinicalTrials.gov record NCT00001118 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002049

PeptideScanner retained ClinicalTrials.gov record NCT00002049 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002050

PeptideScanner retained ClinicalTrials.gov record NCT00002050 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials

Exact-record source chronology

HIV Infections registry timeline

All trial facets →

Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.

2026

2 records

2022

1 record

2021

5 records

2019

1 record

2016

4 records

2015

1 record

2014

1 record

2010

1 record

2008

2 records

2005

12 records
What this brief cannot answer